Clinical trial
Delineating Gut Microbiome and Dietary Determinants Associated With Favorable Vaccine Response
NCT05239403 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Delineating Gut Microbiome and Dietary Determinants Associated With Favorable Vaccine Response
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 24, 2021
- Completion date
- February 28, 2027
- Enrollment
- 74 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza